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Prediction of postoperative 
liver regeneration from clinical 
information using a data-led 
mathematical model
Kimiyo N. Yamamoto1,2,*, Masatsugu Ishii1,*, Yoshihiro Inoue1, Fumitoshi Hirokawa1, 
Ben D. MacArthur3,4, Akira Nakamura5, Hiroshi Haeno2 & Kazuhisa Uchiyama1
Although the capacity of the liver to recover its size after resection has enabled extensive liver 
resection, post-hepatectomy liver failure remains one of the most lethal complications of liver 
resection. Therefore, it is clinically important to discover reliable predictive factors after resection. In 
this study, we established a novel mathematical framework which described post-hepatectomy liver 
regeneration in each patient by incorporating quantitative clinical data. Using the model fitting to 
the liver volumes in series of computed tomography of 123 patients, we estimated liver regeneration 
rates. From the estimation, we found patients were divided into two groups: i) patients restored the 
liver to its original size (Group 1, n = 99); and ii) patients experienced a significant reduction in size 
(Group 2, n = 24). From discriminant analysis in 103 patients with full clinical variables, the prognosis 
of patients in terms of liver recovery was successfully predicted in 85–90% of patients. We further 
validated the accuracy of our model prediction using a validation cohort (prediction = 84–87%, n = 39). 
Our interdisciplinary approach provides qualitative and quantitative insights into the dynamics of 
liver regeneration. A key strength is to provide better prediction in patients who had been judged as 
acceptable for resection by current pragmatic criteria.
Although the capacity of the liver to recover its size after resection has enabled extensive liver resection, liver 
resection is fraught with risk and the potential for complications due to the complex operative interventions1. 
Post-hepatectomy liver failure (PHLF), which is defined as a post-operatively acquired deterioration in the ability 
of the liver to maintain its normal functions, remains one of the most life-threatening complications. The inci-
dence of PHLF varies between 1.2% and 32% in the literature2. Although platelet count, patient age, graft size, and 
presence of the middle hepatic vein influence liver regeneration following healthy living donor transplantation3–6, 
prognostic factors after liver resection have not been sufficiently identified for cancer patients or patients after 
resection7,8. Although a practical guideline demonstrated criteria for resection in 1983, clinical decision making 
remains complex9. Provision of clear criteria for selecting patients who will benefit from liver resection is thus 
important and urgent.
The liver generally regenerates in a highly organized fashion after surgery, involving hyperplasia of all the cell 
types of the liver10. Imaging modalities essentially help us to assess liver regeneration by demonstrating increases 
in liver volume. Multi-detector row computed tomography (CT) has become an essential tool for evaluating 
the volume of remnant liver. CT volumetry is currently routinely performed when liver resection is planned for 
tumors11,12. In the previous studies, temporal-series CT images provided essential information for establishing a 
mathematical model to elucidate growth kinetics of a focused disease13–16. When considered alongside pre- and 
perioperative clinical records, a large dataset of regeneration images provide a wealth of information with which 
to develop a comprehensive understanding of the various patterns of postoperative liver regeneration. Our study 
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with temporal-series volumetry information will be added to a series of theoretical investigations into the dynam-
ics of liver regeneration reported over the past decade17–20.
The present study investigated the dynamics of liver regeneration using an interdisciplinary approach. The 
final goals were to propose powerful criteria to identify potential clinical predictors for successful liver resec-
tion and to predict the time course of liver regeneration. The clinical dataset consisting of 157 patients con-
tained liver volumetry at three or more time points in 123 patients in Osaka Medical College Hospital, along 
with a range of pre- and postoperative clinical variables. Based on a temporal series of CT images, we developed 
a novel mathematical model of liver regeneration and successfully estimated liver regeneration rate after resec-
tion in each patient. From the estimation of the liver regeneration rates, we found that patients were divided into 
two groups: i) patients restored the liver to its original size (Group 1); and ii) patients experienced a significant 
post-operative reduction in size (Group 2). Using the estimated regeneration rates, we successfully described the 
post-hepatectomy temporal course of liver regeneration in each group. Finally, from linear discriminant analysis 
of regeneration rates using pre- and perioperative information, we proposed a formula to prospectively predict 
whether a new patient is likely to be allocated to Group 1 or Group 2. Importantly, the accuracy of our model 
prediction was validated using a separate cohort consisting of 39 patients. In summary, this study provides a sig-
nificantly increased understanding of liver regeneration thereby informing clinical decision-making for patients 
with malignant or other hepatic diseases, including whether to offer operations and when to offer early adjunct 
therapy to patients who are likely to suffer from poor liver regeneration.
Materials and Methods
Clinical cohorts. Between March 2009 and June 2014, a total of 157 patients (124 men, 33 women) under-
went liver resection at Osaka Medical College in Japan (training cohort) (Table S1 and Fig. S1). The median age 
was 68 years (range, 28–88 years). Baseline characteristics of the study population are provided in Table 1. Liver 
volumetry at five months after operation were available in 109 patients, and three or more time points of CT scans 
were available in 123 patients out of 157 patients, respectively (Table S1 and Fig. S1). On admission, laboratory 
results for aspartate aminotransferase (AST), alanine aminotransferase (ALT), body mass index (BMI), diabetes 
mellitus, total bilirubin, albumin, prothrombin time, platelet count, and hepatitis B virus (HBV) and hepatitis C 
virus (HCV) were routinely collected. The indocyanine green retention rate at 15 min (ICGR15) was examined 
Factor Mean Range
Age (years) 68 28–88
Sex (male/female) 124/33
Diabetes mellitus (yes/no) 48/109
BMI (kg/m2) 22.8 13.9–32.9
Total bilirubin (mg/dL) 0.7 0.2–4.6
Albumin (g/dL) 3.8 2–4.9
AST(IU/L) 41.8 10–158
ALT (IU/L) 39.6 7–174
Prothrombin time (%) 102 50–150
Platelets (× 103/mm3) 19 4.2–49.1
ICGR15 (%) 14.6 2.3–72.2
Child-Pugh score (A/B) 147/10








Metastatic liver tumor 53
Benign liver disease 3
Blood loss (g) 604 0–8280
Resected liver volume (g) 251 5–1380
Operation time (min) 263 50–798
Biliary complication (yes/no) 17/140
Ascites (yes/no) 19/138
Table 1.  Summary of a training cohort (n = 157). Abbreviations: BMI = body mass index; AST = aspartate 
aminotransferase; ALT = alanine aminotransferase; ICGR15 = indocyanine green retention rate at 15 min; 
HCV = hepatitis C virus; HBV = hepatitis B virus; HCC = hepatocellular carcinoma; CCC = cholangiocellular 
carcinoma. Benign liver disease included liver stone and benign liver tumor. Other cancer included 
hemangiosarcoma and intrahepatic bile duct cystadenocarcinoma.
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in 103 patients (Table S1 and Fig. S1). A validation cohort consists of 39 patients who underwent liver resection 
at Osaka Medical College in Japan between June 2014 and May 2016 (Tables S2-S3 and Fig. S1). Full clinical 
variables including ICGR15 and three or more time points volumetry were available in all patients (Table S2). 
Data collection and analysis were approved by the Ethics Committee on Clinical Investigation of Osaka Medical 
College Hospital (Nos 1029 and 1198) and all patients were fully informed of the study design according to pro-
vided written, informed consent to participate in this study. Methods were carried out in accordance with the 
approved guidelines.
Measurement of liver volume. For the calculation of total liver volume, commercial interactive 
volumetry-assist software (SYNAPSE VINCENT; Fujifilm, Tokyo, Japan) was used. Volumetric measurements 
were performed as previously reported21. Major vessels, including the vena cava and extrahepatic portal vein, as 
well as major fissures, such as the fissure for the ligamentum teres, were excluded by hand tracing of organs. The 
circumscribed areas were then automatically multiplied by the CT section thickness of 5 mm, yielding an approx-
imate value for the liver volume. Liver volumes were determined preoperatively and at 1 day, 7 days, and 1, 2, and 
5 months and 1 and 2 years postoperatively.
Surgical procedure and perioperative factors. The criteria for hepatic resection and the details of 
the surgical technique have been described in previous studies22–25. Surgical factors assessed included surgical 
duration, intraoperative blood loss, and resected liver volume. Postoperative complications assessed included 
ascites and biliary complications, which were defined according to the Clavien-Dindo classification of surgical 
complications26,27.
Statistical analysis. Nonlinear least-squares curve fitting was performed to estimate the liver regenera-
tion rate r in each of the 123 and 39 patients in a training and a validation cohorts, respectively. Associations 
between two continuous variables were tested using the Mann-Whitney U test. Categorical variables of sex 
(male/female), diabetes mellitus (yes/no), Child-Pugh classification (A/B), and HBV and HCV infection status 
(yes/no), the presence of ascites, and biliary complication were converted into dichotomized variables (one or 
zero, respectively). Uni- and multivariate linear regressions were performed to test the statistical significance of 
clinicopathological factors on determining regeneration rate r. Pearson’s product-moment correlation was per-
formed to calculate the correlation between paired variables. Factors with Pearson’s correlation coefficient over 
0.8 were defined as correlated. Linear discriminant regression analysis was performed to distinguish two classes 
of liver regeneration. Leave one out cross validation was performed to evaluate the accuracies of predictions by 
linear discriminant functions in a training cohort. All values of P < 0.05 were considered indicative of statisti-
cal significance. Statistical analyses were performed using R version 3.1.0 software (R Foundation for Statistical 
Computation, Vienna, Austria).
Results
The basic mathematical model. To investigate the dynamics of liver regeneration, we developed a novel 
mathematical model that describes the temporal change in liver volume after surgery (Fig. 1). Post-operative 
quantitative clinical data indicated there were two major tendencies of liver regeneration: i) liver restored its orig-
inal size and ii) liver reduced in size. From the aspects of the bi-stable regeneration kinetics of liver, we formulated 
a system with two non-zero equilibrium states. We extended a logistic function which has one non-zero equi-
librium state by adding another equilibrium state. In the model, resected liver volume converges to either of two 
states, K and M: K represents the original volume of the liver in each patient before surgery, while M represents 
the reduced volume. Then, the mathematical model is given by
Figure 1. Mathematical model for liver regeneration. (A) Schematic diagram of the mathematical model of 
liver regeneration after surgical resection. The system possesses two steady states of liver volume, K and M. K 
and M represent saturated volume after liver recovery and shrunken volume after irreversible reduction in size 
due to liver failure, respectively. All cases will converge to one of the two states. Cases converging to K and M are 
denoted by Group 1 and Group 2, respectively. (B) A differential equation for the time change of liver volume 
after surgery. Liver volume and regeneration rate are denoted by y t( ) and r, respectively. A regeneration rate r in 
cases in which liver volume converge to K is estimated to be positive, while negative in a case in which liver 
volume converge to M.
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Here, y(t) denotes liver volume after surgical resection and r denotes the regeneration rate per day. For any initial 
volume y0 between K and M, the dynamics in the model will converge to one of these two states. The analytical 
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. See supplementary information S1 for details of the derivation. Please note that (i) the 
initial liver volume after surgery, y0, was standardized to 1000 in order to compare the dynamics of liver regener-
ation between patients and (ii) initial volume y0 is between K and M in any patients.
To apply this model to clinical classification, we determined K and M in each patient depending on the clinical 
data. K was determined as the original (preoperative) liver volume in each patient by definition (Fig. 2). To deter-
mine M for each patient, we investigated liver volume at five months after resection because volume information 
was available in more patients than at other post-operative time points and the outcome of liver regeneration 
became clear at that time (Table S1). Among 109 patients whose liver volume at five months after operation 
were available, 15 patients showed regeneration less than 90% of preoperative volume (< 0.9y3) at the time and 
decreased in volume after surgery (y1 < 0) (Figs 2 and S1). We investigated how their liver volumes at five months 
after operation depended on their clinical variables, and observed correlations with preoperative liver volume 
and intraoperative blood loss (P = 0.04 and P = 0.06, respectively, Tables S4–S6). Therefore, we defined M for 
each patient as
= − . × − . × + .M 0 129 Preoperative liver volume 0 099 Blood loss 1089 93 (3)
We then estimated regeneration rate r using temporal-series CT images at one preoperative and a maximum 
of seven postoperative time points in each case based on the Equation (2). A regeneration rate r in cases in which 
liver volume converge to K is estimated to be positive, while r is estimated to be negative in a case in which liver 
volume converge to M (Fig. 1).
Estimation of regeneration rate. We utilized our novel mathematical framework to estimate regeneration 
rate r using temporal-series CT images at one preoperative and a maximum of seven postoperative time points. 
By fitting Eq. (2) to the clinical data with the nonlinear least-squares method, we estimated regeneration rate r 
in each of 123 patients who had three or more time points volumetry in a training cohort (Fig. S1). Curve-fitting 
from two representative patients is shown in Fig. 3A. Whether a patient (i) showed regeneration of the liver to 
the original size or (ii) experienced a reduction in size (i.e. whether a patient was estimated to show convergence 
to final liver volume K or M by curve fitting) was also recorded. Preoperative liver volume, resection level, and 
blood loss showed the best correlations with estimated regeneration rate r with statistical significance (P = 0.0011, 
P = 0.0012, and P < 0.001, respectively) (Tables S7–S9).
Liver regeneration dynamics in the two subsets of patients. We investigated the dynamics of liver 
regeneration in the two groups that converged to K or M. Of the 123 patients with liver resection, 99 were esti-
mated to converge to K (Group 1) and 24 were estimated to converge to M (Group 2). We investigated the distri-
bution of regeneration rates in the two groups (Fig. 3B). Then, we predicted the time change in liver volume for 




, : i) ε < 0.1; 
Figure 2. Time course of liver regeneration. Typical time course of liver regeneration. Time zero represents 
the time of resection. The regenerated volume at 5 months after surgery, resected volume, and original 





. For each 
patient, the initial volume after surgery was standardized to 1000. K is defined as preoperative liver volume (= y3). 
Patients who fulfill requirements: (i) volume at 5 months after surgery < 0.9y3 and (ii) y1< 0 are used in M 
estimation (n = 15).
www.nature.com/scientificreports/
5Scientific RepoRts | 6:34214 | DOI: 10.1038/srep34214
ii) 0.1 ≤ ε < 0.3; iii) 0.3 ≤ ε < 0.5; and iv) 0.5 ≤ ε < 0.7 (Fig. 2). We fitted the estimated regeneration rates in each 
subgroup to normal distributions (Fig. S2). Then, we employed two regeneration rates that cut off lower and 
upper 10% of each normal distribution and drew two curves of liver regeneration with Eq. (2), so that 80% of 
cases would be covered between the two curves (Fig. 4). The 80% prediction intervals succeeded in covering 
86.8% and 79.2% of patients converging to K and M, respectively (Fig. 4). Favorable liver regeneration was pre-
dicted in cases converging to K (Group 1) (Fig. 4A–D). By contrast, we observed that the liver tended to decrease 
in size if more than 10% was resected in cases converging to M (Group 2) (Fig. 4E–H). Note that simple estima-
tion of the convergence by using only the initial time point did not predict a long period dynamics of liver regen-
eration. Sixteen of 99 patients who initially experienced decrease in liver volumes eventually recovered their liver 
volume and seven of 24 patients who showed favorable regeneration at early period converged to liver failure 
(Table S10 and Fig. S3).
Threshold of liver regeneration. To identify potential candidates for liver regeneration, we finally inves-
tigated whether the regeneration rate r estimated by our mathematical framework, and therefore the likelihood 
of successful liver regeneration subsequent to resection, could be predicted from independent clinical variables. 
To do this, we performed linear discriminant analysis of regeneration rate r using preoperative clinical factors. 
Linear discriminant analysis finds a linear combination of prognostic factors that best separates two classes in 
the group of patients. The 103 patients with full clinical information available were employed to determine the 
discriminant function D1, given by
= . × − . × + .
× − . ×
+ . × + .
D 0 018 PLT 0 043 ICGR15 0 086
BMI 0 0033 Preoperative liver volume
3 4 Resection level 1 4 (4)
1
If D1 is positive, the volume of resected liver is predicted to converge to K (i.e successful postoperative regen-
eration) while if D1 is negative, the resected liver is predicted to converge to M (i.e poor postoperative regenera-
tion). Using this model, 86.4% of cases were correctly classified, and so were 85.4% of cases with cross validation 
(Table 2).
In addition, we conducted a similar analysis using pre- and perioperative clinical factors (Table 2). In this case, 
the discriminant function D2 was given by
= . × − . × + . × − .
× + . ×
− . × − . × + .
D 0 012 PLT 0 036 ICGR15 0 068 BMI 0 0025
Preoperative liver volume 4 4 Resection level
0 00053 Blood loss 0 00062 Operation time 1 3 (5)
2
The overall predictive accuracy of classification by Eq. (5) was 89.3% and 87.4% without and with cross valida-
tion (Table 2). We finally investigated the prediction accuracy of our model by using a validation cohort (Tables 
S2, S3, and Fig. S1). We confirmed 84.6% and 87.2% of patients were correctly classified by using Equations (4) 
and (5), respectively (Table 3). Note that these equations were generated using clinical variables from previously 
treated 103 patients.
Figure 3. Estimation of liver regeneration rate r. (A) Representatives of non-linear least-squares curve-fitting 
in liver recovery using the temporal course of liver volumetry data. (B) Distribution of regeneration rate r in 
patients in accordance with the two classes of liver regeneration: K or M. Red bars represents cases converging 
to K (Group 1), while blue bars represent cases converging to M (Group 2).
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Figure 4. Prediction of liver regeneration dynamics. Dynamics of liver regeneration with estimated 
regeneration and resection levels. Cases are subdivided into two groups: those in whom liver regained its 
original size (Group 1) (panels A–D); and those who experienced a reduction in liver size (Group 2) (panels 




 (Fig. 2):  
i) ε < 0.1; ii) 0.1 ≤ ε < 0.3; iii) 0.3 ≤ ε < 0.5; and iv) 0.5 ≤ ε < 0.7. Here, y2 and y3 represent resected volume and 
original volume (Fig. 2). Two black curves in each panel represent prediction curves of liver regeneration from 
Eq. (2) using regeneration rates that cut off the upper and lower 10% of regeneration rates from the normal 








(i) Preoperative K 94 81
M 9 8
Total 103 89 89/103 (86.4%)
(ii) Perioperative K 93 82
M 10 10
Total 103 92 92/103 (89.3%)
Leave one out cross validation
(i) Preoperative K 93 80
M 10 8
Total 103 88 88/103 (85.4%)
(ii) Perioperative K 93 81
M 10 9
Total 103 90 90/103 (87.4%)
Table 2.  Discriminant analyses of liver regeneration in a training cohort (n = 103). Accuracies of the 









(i) Preoperative K 36 31
M 3 2
Total 39 33 33/39 (84.6%)
(ii) Perioperative K 35 31
M 4 3
Total 39 34 34/39 (87.2%)
Table 3.  Discriminant analyses of liver regeneration in a validation cohort (n = 39). Accuracies of the 
predictions by linear discriminant functions (Eqs (4) and (5)) with (i) preoperative and (ii) perioperative 
factors.
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Discussion
The main concern in clinical decision-making for management of patients with insufficient liver function involves 
whether the liver will maintain its size and function after surgical resection. In this regard, the investigation of 
liver regeneration dynamics using factors routinely tested in the clinic represents an important issue in practical 
clinical settings. This study adopted a combined clinical and theoretical approach for the goals of identifying 
successful/unsuccessful candidates for liver resection and monitoring post-hepatectomy liver regeneration. This 
translational approach was achieved by establishing a novel mathematical framework with two carrying capaci-
ties of successful/unsuccessful liver regeneration. We first obtained numerical estimates of liver regeneration in 
each patient based on the mathematical model and CT image data. We confirmed that the model represented the 
temporal course of liver regeneration in both subgroups. We then predicted whether patients would experience 
successful/unsuccessful regeneration by conducting discriminant analysis. Finally, we confirmed the prediction 
accuracy of our model by using a validation cohort. Because all the factors used in the analyses are routinely 
recorded in clinic settings, our model is routinely clinically applicable and is therefore directly testable in clinical 
trials.
This study demonstrated a method to predict whether the liver of a patient will succeed in recovering, with 
accuracies as high as 84–88% in both of a training cohort with cross validation and a separate validation cohort 
by utilizing mathematical tools (Eqs (4) and (5), Tables 2 and 3). As a number of studies addressed, the major 
concern in PHLF is to be a predominant cause of hepatectomy-related mortality2. In fact, when we investigated 
on patients with hepatobiliary primary diseases (HCC, CCC, and hepatic benign tumor, n = 76), the patients who 
converged to M (Group 2) showed worse survival outcome than those who converged to K (Group 1) (Fig. S4A). 
We tested if the discriminant equations, which were derived in order to distinguish patients in terms of the liver 
recovery, could classify patients in terms of survivorship. Interestingly, we succeeded in predicting significant 
difference in survival outcomes between the two groups when we stratified patients by including perioperative 
information in the discriminant Equation (5), although we did not find a significant difference by Equation (4) 
(Fig. S4B,C). By contrast to hepatobiliary primary disease, all patients with metastatic disease (n = 27) converged 
to K (Group 1). The discriminant Equations (4) and (5) perfectly classified patients with metastatic disease in K 
(Fig. S5). This may occur due to the baseline normal liver function in metastatic disease. These results indicate 
that our method is able to reliably identify patients who are likely to experience unsuccessful liver regeneration 
and develop life-threatening post-hepatectomy complications.
To aid understanding of our method the schematic in Supplementary Figure 6 summarizes our method. 
Critically, if the solution of the discriminant equation is positive, then we predict with good accuracy that the 
liver of the patient is likely to recover to the original size (80 of 93 K-predicted patients with cross validation) 
(Tables 2 and 3). In this case, surgery can be planned by considering the greatest benefit to the patient. However, 
if the solution is negative, then the patient is likely to experience poor liver regeneration (8 of 10 M-predicted 
patients with cross validation) (Tables 2 and 3). In this situation, avoiding resection is one treatment option; alter-
natively, minimally invasive procedures, which reduce operation time, intraoperative blood loss and the risk of 
postoperative complications28,29 (perioperative factors which contribute to liver recovery and therefore survival, 
see Eq. (5)), should be considered. Indeed, by including perioperative information in the discriminant equation, 
more precise patient stratification could be obtained (Tables 2 and 3). In this case, we predicted with good accu-
racy that 81 of 93 K-predicted patients showed recovery to the original size; and 9 of 10 M-predicted displayed 
unfavorable liver regeneration (Tables 2 and 3). We accurately predicted the subsequent poor survival outcomes 
of patients with hepatobiliary primary cancer who experienced a significant post-operative reduction in size 
(Fig. S4C). Since all patients enrolled in this study had once been judged as acceptable for resection by clinicians 
according to the current pragmatic criteria, a key strength of our model is the ability to provide better prediction 
even in this ‘acceptable’ cohort. Therefore our method provides more refined criteria for prediction of the success 
of postoperative liver regeneration, and particularly allows identification of patients who are at a greater risk of 
liver failure and subsequent low survivorship following surgery.
Another important clinical implication of this study is that we provide the quantification of the dynamics of 
liver regeneration so that we can predict the temporal course of liver regeneration in categorized patients (i.e., 
estimated regeneration rate r) (Fig. 4). Our model successfully reproduced several regeneration modes presented 
in a recent study20. From their classification, patients may experience delayed recovery or unchanged liver volume 
after surgery. When a regeneration rate r in our model is large, a rapid regeneration after surgery is expected, 
whereas a delayed regeneration is expected when it is small (Fig. S7). We recognized the profiles of a subset of 
patients did not match the two distinct steady states but represented unresponsive regeneration. To see whether 
these cases affect the prediction accuracy, we performed a linear discriminant analysis by omitting cases in which 
all time points of liver volume after resection were within 1000 ± 100 (the number of omitted cases was 14 out of 
103 patients). The total predictive accuracy changed from 85.4% and 87.4% with pre- and perioperative factors 
with cross validation, respectively, to 85.4% and 88.8% with pre- and perioperative factors with cross validation, 
which indicated the predictive accuracies were comparable (Table S11). We therefore concluded that our model 
using the clinical patient-specific value of r had a predictive capacity for heterogeneous patient populations with 
various type of regeneration modes. Since we assume that K is fixed as the original liver volume, our model 
assumption does not include enhanced regeneration. This can be addressed in future studies. Our results also 
theoretically support previous findings that a rapid liver regeneration during the first month and small changes in 
liver volume after the first month is expected when a patient has a functional liver (Figs 4 and S7)21,30,31. In prac-
tical settings, clinicians can select potential candidates who will need close follow-up or adjunctive therapy early 
by identifying those who do not reach the predicted regeneration curve.
We used liver regeneration rates estimated by using their overall temporal-series CT images, but not their ini-
tial measurements postoperatively, to determine whether patients’ trajectories further proceeded in the positive 
or negative direction. This was necessary because postoperative liver volume in an early postoperative period did 
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not always predict their prognosis in liver volume in a longer period; 16 out of 99 patients converged to K and 
7 out of 24 patients converged to M failed to be estimated accurately (Table S10 and Fig. S3). Several inherent 
limitations must be also considered when interpreting the findings of the present study. First, although patients 
in the current study were enrolled and examined prospectively under the same follow-up protocol, we needed to 
omit patients during the eligibility period because of the lack of several clinical factors. This would have slightly 
reduced the continuity of the patient population. Second, recent studies have reported that other factors such as 
hepatocyte growth factor are associated with liver regeneration potency30,32,33. Most patients lack such data and 
future studies should include these factors into analyses for better predictive models. Our modestly sized cohort 
included a heterogeneous population under different treatment therapies according to disease, which might influ-
ence liver regeneration capability. Despite that, Equation (2) reproduces the dynamics of liver regeneration and 
provides better prediction in patients than the current pragmatic criteria. Finally, discriminant equations were 
generated retrospectively using clinical cohorts that received hepatectomy according to the current practical clin-
ical criteria9. Due to the criteria, there was a limitation in the resectable liver volume; e.g. a case with high ICGR15 
and low PLT levels, which indicate their impaired liver baseline function, could not receive larger liver resection 
in principle. Patients who could receive large resection had originally favorable liver function so that the contri-
bution of resection level were positive in discriminant equations.
The liver maintains a delicate balance between volume loss and excess growth, based on complex molecular 
mechanisms30. A number of mechanisms for regulating liver size have been investigated, including the roles of 
cytokines, growth factors, matrix remodeling, and metabolic signals10. Recent mathematical models developed 
for liver regeneration have served well as predictors for estimating the effects of regeneration networks on the 
liver remnant17–20. However, such results are preliminary, and have yet to be translated into actual clinical benefits, 
because the signaling pathway frameworks were based on animal models. In this regard, our study is advanta-
geous since it yields a prediction of liver regeneration after surgery only using commonly obtained laboratory data 
on admission. Here, routine testing of ICG clearance is also recommended, as a safe, dynamic tool for quantifying 
liver function34,35. Our simple mathematical framework is therefore highly applicable and can be directly tested 
in the clinic.
In conclusion, we have proposed an intuitive, universal mathematical model of liver regeneration. The inter-
disciplinary approach employing this mathematical framework and clinical data provides both qualitative and 
quantitative insights into the dynamics of liver regeneration. As the number in the cohort increases, we expect our 
methodology will provide more accurate predictions and monitoring tools for post-hepatectomy liver regenera-
tion, allowing precise tailoring treatment regimens to individual patients.
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